Filing Details
- Accession Number:
- 0001203311-12-000008
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2012-03-01 17:17:19
- Reporting Period:
- 2012-02-28
- Filing Date:
- 2012-03-01
- Accepted Time:
- 2012-03-01 17:17:19
- Original Submission Date:
- 2012-02-29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202785 | Eric Dobmeier | 21823 30Th Drive Se Bothell WA 98021 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-02-28 | 4,000 | $18.53 | 68,073 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- $18.5285 represents an average price per share for the shares sold on 2/28/12. The sell price for shares sold on this day ranged from $18.50 to $18.57.
- Amount of securities beneficially owned following reported transactions includes 25,220 Restricted Stock Units subject to vesting.